Advertisement

Analytical and Bioanalytical Chemistry

, Volume 385, Issue 4, pp 692–699 | Cite as

Strategies for examination of Alzheimer’s disease amyloid precursor protein isoforms

  • Jillian R. A. Newton
  • David Parkinson
  • Malcolm R. ClenchEmail author
Original Paper

Abstract

We describe a proteomics procedure using bioinformatics, immunoprecipitation, two-dimensional gel electrophoresis, Western blotting, in-gel digestion, LC–MS, MALDI–MS, and MS–MS for isolation and identification of amyloid precursor protein (APP) isoforms APP695, APP751, and APP770. Retinoic acid-induced Ntera 2 cell line, derived from a human teratocarcinoma cells, was the in-vitro source of APP. Initial isolation of whole APP was performed by immunoprecipitation, using AB10, a monoclonal antibody raised to amino acids 1–17 of the β-amyloid peptide sequence, which is present in all three alpha secretase-cleaved isoforms of interest. The next stage was separation of whole APP into its isoform components by two-dimensional gel electrophoresis. Because of low APP concentrations, detection by the usual staining methods, for example Sypro Ruby, able to detect low picomole concentrations, did not enable visualisation of the isoforms. Western analysis, however, enabled primary detection of APP, because of the inherent sensitivity of antibodies raised to specific isoform regions. This initial visualization acted as a template for excision of isoforms from 2D gels, which were then subjected to peptide mass mapping. Initial theoretical digestion of each isoform revealed the presence of specific peptides, which were then used as “tags” for isoform detection.

Keywords

Amyloid precursor protein Isoforms Proteomics Mass spectrometry 

References

  1. 1.
    Kidd M (1964) Alzheimers Disease-An electronmicroscopical study. Brain 87:307–320CrossRefGoogle Scholar
  2. 2.
    Terry RD, Gonatas HK, Weiss M (1964) Ultrastructural studies in Alzheimer’s predementia. Am J Pathol 44:269–297Google Scholar
  3. 3.
    Roth M, Tomlinson BE, Blessed G (1966) Correlation between scores for dementia and counts of senile plaques in cerebral grey matter of elderly subjects. Nature 209:109–110CrossRefGoogle Scholar
  4. 4.
    Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733–736CrossRefGoogle Scholar
  5. 5.
    Selkoe DJ, Bell DS, Podlisny MB, Price DL, Cork LC (1987) Conservation of brain amyloid proteins in aged mammals with Alzheimer’s disease. Science 235:873–877CrossRefGoogle Scholar
  6. 6.
    Johnstone EM, Chaney MO, Norris FH, Pascal R, Little SP (1991) Conservation of the sequence of Alzheimer’s disease amyloid peptide in dog, polar bear and five other mammals by cross species polymerase chain reaction analysis. Mol Brain Res 10:291–305CrossRefGoogle Scholar
  7. 7.
    De Sauvage F, Octave JN (1989) A novel mRNA of the A4 amyloid precursor gene coding for a possible secreted protein. Science 245:651–653CrossRefGoogle Scholar
  8. 8.
    Pahlsson P, Spitalnik SL (1996) The role of glycosylation in synthesis and secretion of beta amyloid precursor protein by Chinese hamster ovary cells. Arch Biochem Biophys 331:177–186CrossRefGoogle Scholar
  9. 9.
    Godfroid E, Octave JN (1990) Glycosylation of the Amyloid peptide precursor containing the Kunitz protease inhibitor domain improves the inhibition of trypsin. Biochem Biophys Res Commun 171:1015–1021CrossRefGoogle Scholar
  10. 10.
    Russo C, Venezia V, Repetto E, Nizzari M, Violani E, Carlo P, Schettini G (2005) The amyloid precursor protein and its network of interacting proteins: physiological and pathological implications. Brains Res Rev 48:257–264CrossRefGoogle Scholar
  11. 11.
    Umehara Y, Yamada S, Nishimura S, Shioi J, Robakis NK, Sugahara K (2004) Chondroitin sulfate of appican, the proteoglycan form of amyloid precursor protein, produced by C6 glioma cells, interacts with heparin binding neuroregulatory factors. FEBS Letters 557:233–238CrossRefGoogle Scholar
  12. 12.
    Wasco W, Bupp K, Magantantz M, Gusella JF, Tanzi RE, Solomon F (1987) Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer’s associated amyloid beta protein precursor. Proc Natl Acad Sci USA 89:10758–10762CrossRefGoogle Scholar
  13. 13.
    Yoshikai S, Sasaka H, Doh-ura K, Furuya H, Sasaki Y (1990) Genomic organisation of the human amyloid beta protein precursor gene. Gene 87:257–263CrossRefGoogle Scholar
  14. 14.
  15. 15.
    Kitaguchi N, Takahashi Y, Okushima Y, Shiojiri S, Ito H (1988) Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity. Nature 331:530–532CrossRefGoogle Scholar
  16. 16.
    Tanzi RE, McClatchey AJ, Lamperti ED, Villa-Komaroff L, Gusella, Neve RL (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer’s disease. Nature 331:528–530CrossRefGoogle Scholar
  17. 17.
    Kang J, Muller-Hill B (1990) Differential splicing of Alzheimer’s disease amyloid A4 precursor RNA in rat tissues: Pre A4 (695) mRNA is predominantly produced in rat and human brain. Biochem Biophys Res Commun 166:1192–1200CrossRefGoogle Scholar
  18. 18.
    Clark MJ, Gagnon J, Williams AF, Barclay AN (1985) MRC OX2 antigen: a lymphoid/neuronal glycoprotein with a structure like a single immunoglobulin light chain. Journal of the European Molecular Biology Organisation 4:113–118Google Scholar
  19. 19.
    Schilling J, Wang Y, Lau K, Smith L, Cordell B (1991) Synthesis and characterization of the Kunitz protease-inhibitor domain of the β-amyloid precursor protein. Gene 98:225–230CrossRefGoogle Scholar
  20. 20.
    Abe K, Tanzi RE, Kogure K (1991) Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci Lett 125:172–174CrossRefGoogle Scholar
  21. 21.
    Clark AW, Parhad IM (1989) Expression of neuronal mRNA’s in Alzheimer type degeneration of the nervous system. Can J Neurol Sci 16:477–482Google Scholar
  22. 22.
    Clark AW, Krekoski CA, Parhad IM, Liston D, Hoar DI (1989) Altered expression of genes for amyloid and cytoskeletal proteins in Alzheimer’s cortex. Annual Reviews in Neurology 25:331–339CrossRefGoogle Scholar
  23. 23.
    Golde TE, Estus S, Usiak M, Younkin LH, Younkin SG (1990) Expression of beta amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer’s disease using PCR. Neuron 4:253–267CrossRefGoogle Scholar
  24. 24.
    Harrison PJ, Barton AJ, Procter AW, Bowen DM, Pearson RC (1994) The effects of Alzheimer’s disease, other dementias and premortem course on beta-amyloid precursor messenger RNA in frontal cortex. J Neurochem 62:635–644CrossRefGoogle Scholar
  25. 25.
    Harrison PJ, Wighton-Benn WH, Heffeman JM, Sanders MW, Pearson RC (1996) Amyloid precursor protein mRNAs in Alzheimer’s disease. Neurodegeneration 5:409–415CrossRefGoogle Scholar
  26. 26.
    Jacobsen JSD, Blume AJ, Vitek MP (1991) Quantitative measurement of alternatively spliced amyloid precursor protein mRNA expression in Alzheimer’s disease and normal; brain by S1 nuclease protection analysis. Neurobiol Aging 12:585–592CrossRefGoogle Scholar
  27. 27.
    Johnson SA, Pasinetti GM, May PC, Ponte PA, Cordell B, Finch CE (1988) Selective reduction of mRNA for the beta-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains. Experimental Neurology 102:264–268CrossRefGoogle Scholar
  28. 28.
    Johnson SA, McNeill T, Cordell B, Finch CE (1990) Relation of neuronal APP751/770 mRNA ratio and neuritic plaque density in Alzheimer’s disease. Science 248:854–857CrossRefGoogle Scholar
  29. 29.
    Shepherd CE, Bowes S, Parkinson D, Cambray-Deakin M, Pearson CA (2000) Expression of amyloid precursor protein in human astrocytes in vitro: Isoform specific increases following heat shock. Neuroscience 99:325–371CrossRefGoogle Scholar
  30. 30.
    Johnson T (1996) Current Protocols in Protein Science, supplement 6, John Wiley & SonsGoogle Scholar
  31. 31.
    Beyer K, Lao JI, Carrato C, Mate JL, Lopez D, Ferrer I, Ariza A (2004) Upregulation of amyloid precursor protein isoforms containing Kunitz protease inhibitor in dementia with Lewy bodies. Mol Brain Res 131:131–135CrossRefGoogle Scholar
  32. 32.
    Thakur MK, Man ST (2005) Estradiol regulates APP mRNA alternative splicing in the mice brain cortex. Neurosci Lett 381:154–157CrossRefGoogle Scholar
  33. 33.
    Fehlbaum P, Guihal C, Bracco L, Cochet O (2005) A microarray configuration to quantify expression levels and relative abundance of splice variants, Nucleic Acids research 33 e47 OPEN ACCESS ARTICLEGoogle Scholar
  34. 34.
  35. 35.
    Lopez MF, Berggren K, Chernokalskaya E, Lazarev A, Robinson M, Patton WF (2000) A comparison of silver stain and Sypro ruby protein gel stain with respect to protein detection in two dimensional gels and identification by peptide mass profiling. Electrophoresis 21:3673–3683CrossRefGoogle Scholar
  36. 36.
    Rabilloud T, Strub JM, SLuche, Dorsselaer A, Lunardi JA (2001) A comparison between Sypro Ruby and ruthenium II tris (bathphenanthroline disulfonate) as fluorescent stains for protein detection in gels. Proteomics 1:699–704CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Jillian R. A. Newton
    • 1
  • David Parkinson
    • 1
  • Malcolm R. Clench
    • 1
    Email author
  1. 1.Biomedical Research CentreSheffield Hallam UniversitySheffieldUK

Personalised recommendations